• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.35% Nasdaq Down 0.29%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    19.17 Down 0.45(2.27%) 2:15PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:19.61
    Open:19.60
    Bid:19.09 x 100
    Ask:19.10 x 100
    1y Target Est:20.38
    Beta:1.88
    Earnings Date:Jul 29 - Aug 3 (Est.)
    Day's Range:18.93 - 19.63
    52wk Range:9.38 - 20.75
    Volume:391,423
    Avg Vol (3m):1,031,180
    Market Cap:1.11B
    P/E (ttm):N/A
    EPS (ttm):-1.78
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MNTA

    Comparison

    Symbol% ChgMkt Cap
    MNTADown 2.27%1.11B
    GSKUp 0.27%108.02B
    SNYDown 0.56%131.81B
    TEVAUp 0.77%51.87B

    Key Statistics

    Forward P/E (1 yr):32.36
    P/S (ttm):22.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.57
    Quarterly EPS Est (Jun-15) :-0.36
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback